Cipla Collaborates with Kemwell and Manipal for Global Development of Innovative Cell Therapy | |
Cipla, a global pharmaceutical company, has entered into a strategic collaboration with Kemwell Biopharma and Manipal Education & Medical Group to establish a joint venture in the United States. This joint venture aims to focus on the development and commercialization of innovative cell therapy products to address significant unmet medical needs in the US, Japan, and EU regions. As part of the collaboration, Cipla (EU), a wholly-owned subsidiary of Cipla, will hold a 35% stake in the joint venture company. The collaboration brings together Cipla’s expertise in product development and commercialization, Kemwell’s proficiency in biologics, and Manipal’s experience in healthcare delivery. For more details please visit our website - https://www.medhealthinsight.com/new-soundboard-review-pricing-is-not-always-the-only-criteria-2-11-2-79/ ![]() | |
| Related Link: Click here to visit item owner's website (0 hit) | |
| Target State: New York Target City : New work city Last Update : Nov 07, 2025 5:31 AM Number of Views: 9 | Item Owner : medhealthinsight Contact Email: (None) Contact Phone: (None) |
| Friendly reminder: Click here to read some tips. | |